Summary of Significant Accounting Policies (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Changes in Deferred Commissions |
Changes in deferred commissions for the years ended December 31, 2020 and 2019 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
2019 |
| Balance, beginning of the period |
$ |
309 |
|
|
$ |
369 |
|
| Deferral of commissions earned |
94 |
|
|
171 |
|
| Recognition of commission expense |
(193) |
|
|
(231) |
|
| Balance, end of the period |
$ |
210 |
|
|
$ |
309 |
|
|
| Schedule of Concentration Risk |
The following table sets forth our concentration of accounts receivable, net of specific allowances for doubtful accounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
| Customer A |
— |
% |
|
15 |
% |
| Customer B |
55 |
% |
|
11 |
% |
| Customer C |
16 |
% |
|
2 |
% |
| Customer D |
13 |
% |
|
5 |
% |
| Customer E |
— |
% |
|
10 |
% |
| Customer F |
5 |
% |
|
23 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2020 |
|
2019 |
| Customer A |
32 |
% |
|
8 |
% |
| Customer G |
12 |
% |
|
7 |
% |
|
| Schedule of Accounts Receivable |
Accounts receivable consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
| Accounts receivable |
$ |
1,020 |
|
|
$ |
4,850 |
|
| Less allowances for doubtful accounts |
(356) |
|
|
(3,179) |
|
| Accounts receivable, net |
$ |
664 |
|
|
$ |
1,671 |
|
|
| Schedule of Allowance for Doubtful Debt |
Changes in the allowance for doubtful accounts are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
| Balance, beginning of period |
$ |
3,179 |
|
|
$ |
3,276 |
|
| Allowances for bad debt |
205 |
|
|
114 |
|
| Issuance of credit memos and write offs |
(3,028) |
|
|
(211) |
|
| Balance, end of period |
$ |
356 |
|
|
$ |
3,179 |
|
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following table sets forth common stock equivalents that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
| Convertible notes |
5,733,712 |
|
|
21,740 |
|
| Warrants |
5,996,112 |
|
|
3,836,112 |
|
| Options |
1,208,740 |
|
|
1,465,450 |
|
| Restricted stock units |
1,677,060 |
|
|
2,436,968 |
|
| Restricted shares |
574 |
|
|
6,219 |
|
| Total |
14,616,198 |
|
7,766,489 |
|
| Financial Instruments Measured at Fair Value |
Determining which category an asset or liability falls within the hierarchy requires significant judgment. Our financial instruments measured at fair value as of December 31, 2020 are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
| Liabilities: |
|
|
|
|
|
|
|
| Warrant liability |
$ |
— |
|
|
$ |
1,614 |
|
|
$ |
— |
|
|
$ |
1,614 |
|
| Total |
$ |
— |
|
|
$ |
1,614 |
|
|
$ |
— |
|
|
$ |
1,614 |
|
|